- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 39/10 - BrucellaBordetella, e.g. Bordetella pertussis
Patent holdings for IPC class A61K 39/10
Total number of patents in this class: 211
10-year publication summary
13
|
3
|
6
|
6
|
8
|
7
|
5
|
5
|
5
|
2
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Institut Pasteur de Lille | 175 |
17 |
Institut National de La Sante et de La Recherche Medicale (inserm) | 2880 |
14 |
Glaxosmithkline Biologicals S.A. | 1650 |
7 |
National University of Singapore | 2460 |
7 |
Novartis AG | 10726 |
4 |
Inserm (institut National de La Sante et de La Recherche Medicale) | 3364 |
4 |
Intervet International B.V. | 1296 |
4 |
Zoetis Services LLC | 1536 |
4 |
Board of Regents, The University of Texas System | 5841 |
3 |
Adjuvance Technologies, Inc., AKA Adjuvance | 22 |
3 |
Consejo Nacional de Investigaciones Cientificas y Tecnicas (conicet) | 304 |
3 |
Inis Biotech LLC | 99 |
3 |
Memorial Sloan-Kettering Cancer Center | 1940 |
3 |
National University of Ireland Maynooth | 79 |
3 |
Panacea Biotec Ltd. | 78 |
3 |
Serum Institute of India Private Limited | 101 |
3 |
SNIPR Biome ApS | 51 |
3 |
The Regents of the University of California | 20035 |
2 |
The Regents of the University of Michigan | 4733 |
2 |
The Arizona Board of Regents on Behalf of the University of Arizona | 2173 |
2 |
Other owners | 117 |